PHARMACISTS MUTUAL ANNOUNCES BOARD TRANSITIONS, HONORS RETIRING DIRECTORS AND WELCOMES NEW MEMBERS

ALGONA, Iowa, May 15, 2026 /PRNewswire/ — Pharmacists Mutual Insurance Group (“Pharmacists Mutual”) announces the retirement…

MINISH Veneers USA Successfully Concludes Biomimetic Veneers Course at VITA North America

LOS ANGELES, May 15, 2026 /PRNewswire/ — MINISH Veneers USA successfully concluded its latest U.S. MINISH…

Brayton Purcell LLP Calls Attention to Capital & Main Video Report Highlighting Deadly Artificial Stone Silicosis Crisis Among California Stonecutters

NOVATO, Calif., May 15, 2026 /PRNewswire/ — A newly released video report from Capital & Main…

Propedix Announces Appointment of Dr. Mercedes E. Gonzalez to its Clinical Advisory Board

BOSTON, May 15, 2026 /PRNewswire/ — Propedix today announced the appointment of board-certified pediatric dermatologist Dr.…

MARPAI REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS

Strategic Investments in Operations and Technology Fuel Platform for Accelerated Growth and Aim of Second-Half 2026…

Accuray and the University of Wisconsin-Madison Announce Master Research Agreement to Improve Personalized Care for Patients with Cancer

MADISON,Wis., May 15, 2026 /PRNewswire/ — Accuray Incorporated (NASDAQ: ARAY) and the University of Wisconsin School…

BrainStorm Cell Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update

NEW YORK, May 15, 2026 /PRNewswire/ — BrainStorm Cell Therapeutics Inc. (OTCQB: BCLI), a leading developer…

Citius Oncology, Inc. Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update

$5.6 million in net revenue for the first half of fiscal 2026 as LYMPHIR® launch progressesUp…

Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update

$5.6 Million in net revenue for the first half of fiscal 2026 from ongoing launch of…

TuHURA Biosciences Reports First Quarter 2026 Financial Results and Provides a Corporate Update

TAMPA, Fla., May 15, 2026 /PRNewswire/ — TuHURA Biosciences, Inc. (NASDAQ: HURA) (“TuHURA” or the “Company”),…